TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: This property was not only limited to Ph+ LSCs, as Ph-negative (Ph-) HSCs in CML patients poorly responding to therapy also showed increased levels of TGF-β and TNF-α signaling, indicating disruption of the whole microenvironment [27].